The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Circulating microRNAs as stable blood-based markers for cancer detection
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969
Non-coding RNAs in human disease
Esteller, M. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3074 · Cited by 4,825
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
The MicroRNA Spectrum in 12 Body Fluids
Weber, J. A., Baxter, D. H., Zhang, S., Huang, D. Y., How Huang, K., Jen Lee, M., Galas, D. J., & Wang, K. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.147405 · Cited by 2,477
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
Esau, C., Davis, S., Murray, S. F., Yu, X. X., Pandey, S. K., Pear, M., Watts, L., Booten, S. L., Graham, M., McKay, R., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.005 · Cited by 2,082
LNA-mediated microRNA silencing in non-human primates
Elmén, J., Lindow, M., Schütz, S., Lawrence, M., Petri, A., Obad, S., Lindholm, M., Hedtjärn, M., Hansen, H. F., Berger, U., et al. (2008) · Nature · doi:10.1038/nature06783 · Cited by 1,589
MicroRNAs in body fluids—the mix of hormones and biomarkers
Cortez, M. A., Bueso-Ramos, C., Ferdin, J., Lopez-Berestein, G., Sood, A. K., & Calin, G. A. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.76 · Cited by 1,465
MicroRNA-10a binds the 5’UTR of ribosomal protein mRNAs and enhances their translation
Ørom, U. A., Nielsen, F. C., & Lund, A. H. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.05.001 · Cited by 1,384
Serum MicroRNAs Are Promising Novel Biomarkers
Gilad, S., Meiri, E., Yogev, Y., Benjamin, S., Lebanony, D., Yerushalmi, N., Benjamin, H., Kushnir, M., Cholakh, H., Melamed, N., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003148 · Cited by 1,347
The miR-34 family in cancer and apoptosis
Hermeking, H. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.56 · Cited by 1,236
Kroh, E. M., Parkin, R. K., Mitchell, P. S., & Tewari, M. (2010) · Methods · doi:10.1016/j.ymeth.2010.01.032 · Cited by 1,175
Circulating microRNAs, potential biomarkers for drug-induced liver injury
Wang, K., Zhang, S., Marzolf, B., Troisch, P., Brightman, A., Hu, Z., Hood, L. E., & Galas, D. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813371106 · Cited by 1,149
Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis
Rolo, A. P., Teodoro, J. S., & Palmeira, C. M. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.003 · Cited by 955
Nonalcoholic Fatty Liver Disease: Pathology and Pathogenesis
Tiniakos, D. G., Vos, M. B., & Brunt, E. M. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102132 · Cited by 870
Salivary microRNA: Discovery, Characterization, and Clinical Utility for Oral Cancer Detection
Park, N. J., Zhou, H., Elashoff, D., Henson, B. S., Kastratovic, D. A., Abemayor, E., & Wong, D. T. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0736 · Cited by 843
microRNAs in cancer management
Kong, Y. W., Ferland-McCollough, D., Jackson, T. J., & Bushell, M. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70073-6 · Cited by 734
Analysis of Circulating MicroRNA: Preanalytical and Analytical Challenges
McDonald, J. S., Milosevic, D., Reddi, H. V., Grebe, S. K., & Algeciras-Schimnich, A. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.157198 · Cited by 679
Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression
Cheung, O., Puri, P., Eicken, C., Contos, M. J., Mirshahi, F., Maher, J. W., Kellum, J. M., Min, H., Luketic, V. A., & Sanyal, A. J. (2008) · Hepatology · doi:10.1002/hep.22569 · Cited by 658
Xu, J., Wu, C., Che, X., Wang, L., Yu, D., Zhang, T., Huang, L., Li, H., Tan, W., Wang, C., et al. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20712 · Cited by 567
Circulating MicroRNAs in Patients with Chronic Hepatitis C and Non-Alcoholic Fatty Liver Disease
Cermelli, S., Ruggieri, A., Marrero, J. A., Ioannou, G. N., & Beretta, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023937 · Cited by 564
Circulating microRNAs as potential markers of human drug-induced liver injury
Starkey Lewis, P. J., Dear, J., Platt, V., Simpson, K. J., Craig, D. G. N., Antoine, D. J., French, N. S., Dhaun, N., Webb, D. J., Costello, E. M., et al. (2011) · Hepatology · doi:10.1002/hep.24538 · Cited by 515
Interobserver and Intraobserver Variability in the Sonographic Assessment of Fatty Liver
Strauss, S., Gavish, E., Gottlieb, P., & Katsnelson, L. (2007) · American Journal of Roentgenology · doi:10.2214/ajr.07.2123 · Cited by 478
Castro, R. E., Ferreira, D. M. S., Afonso, M. B., Borralho, P. M., Machado, M. V., Cortez-Pinto, H., & Rodrigues, C. M. P. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.08.008 · Cited by 350
Armstrong, M. J., Houlihan, D. D., Bentham, L., Shaw, J. C., Cramb, R., Olliff, S., Gill, P. S., Neuberger, J. M., Lilford, R. J., & Newsome, P. N. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.03.020 · Cited by 300
Wang, X. W., Heegaard, N. H. H., & Ørum, H. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.007 · Cited by 280
The Emerging Role of MicroRNAs in Cardiac Remodeling and Heart Failure
Divakaran, V., & Mann, D. L. (2008) · Circulation Research · doi:10.1161/circresaha.108.183087 · Cited by 267
Role of microRNAs in kidney homeostasis and disease
Chandrasekaran, K., Karolina, D. S., Sepramaniam, S., Armugam, A., Marelyn Wintour, E., Bertram, J. F., & Jeyaseelan, K. (2012) · Kidney International · doi:10.1038/ki.2011.448 · Cited by 219
Circulating MicroRNA Profiles as Potential Biomarkers for Diagnosis of Papillary Thyroid Carcinoma
Yu, S., Liu, Y., Wang, J., Guo, Z., Zhang, Q., Yu, F., Zhang, Y., Huang, K., Li, Y., Song, E., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3059 · Cited by 207
Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk.
Pacifico, L., Nobili, V., Anania, C., Verdecchia, P., & Chiesa, C. (2011) · PubMed · doi:10.3748/wjg.v17.i26.3082 · Cited by 198
Alisi, A., Da Sacco, L., Bruscalupi, G., Piemonte, F., Panera, N., De Vito, R., Leoni, S., Bottazzo, G. F., Masotti, A., & Nobili, V. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2010.166 · Cited by 194
Pogribny, I. P., Starlard-Davenport, A., Tryndyak, V. P., Han, T., Ross, S. A., Rusyn, I., & Beland, F. A. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.113 · Cited by 185
Differential expression of microRNAs in mouse liver under aberrant energy metabolic status
Li, S., Chen, X., Zhang, H., Liang, X., Xiang, Y., Yu, C., Zen, K., Li, Y., & Zhang, C.-Y. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800509-jlr200 · Cited by 184
MicroRNAs: Novel regulators of immunity
Carissimi, C., Fulci, V., & Macino, G. (2009) · Autoimmunity Reviews · doi:10.1016/j.autrev.2009.01.008 · Cited by 161
Fu, T., Choi, S., Kim, D.-H., Seok, S., Suino-Powell, K. M., Xu, H. E., & Kemper, J. K. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205951109 · Cited by 160
Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression
Farrell, G. C., Larter, C. Z., Hou, J. Y., Zhang, R. H., Yeh, M. M., Williams, J., Dela Peňa, A., Francisco, R., Osvath, S. R., Brooling, J., et al. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05785.x · Cited by 120
Expression of p53, Bax and Bcl-2 proteins in hepatocytes in non-alcoholic fatty liver disease
Panasiuk, A. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i38.6198 · Cited by 108
Scaglioni, F., Ciccia, S., Marino, M., Bedogni, G., & Bellentani, S. (2011) · Digestive Diseases · doi:10.1159/000323886 · Cited by 95
Managing the combination of nonalcoholic fatty liver disease and metabolic syndrome
Moscatiello, S., Luzio, R. D., Sasdelli, A. S., & Marchesini, G. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.629188 · Cited by 21
Cited by
miR-122 – A key factor and therapeutic target in liver disease
Bandiera, S., Pfeffer, S., Baumert, T. F., & Zeisel, M. B. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.004 · Cited by 629
The p53/miR-34 axis in development and disease
Rokavec, M., Li, H., Jiang, L., & Hermeking, H. (2014) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mju003 · Cited by 354
Specific miRNA Disease Biomarkers in Blood, Serum and Plasma: Challenges and Prospects
Backes, C., Meese, E., & Keller, A. (2016) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-016-0221-4 · Cited by 340
Ding, J., Li, M., Wan, X., Jin, X., Chen, S., Yu, C., & Li, Y. (2015) · Scientific Reports · doi:10.1038/srep13729 · Cited by 261
miR-21: a non‐specific biomarker of all maladies
Jenike, A. E., & Halushka, M. K. (2021) · Biomarker Research · doi:10.1186/s40364-021-00272-1 · Cited by 248
Metadata
- Authors
- Yamada, H., Suzuki, K., Ichino, N., Ando, Y., Sawada, A., Osakabe, K., Sugimoto, K., Ohashi, K., Teradaira, R., Inoue, T., Hamajima, N., & Hashimoto, S.
- Venue
- Clinica Chimica Acta
- Publisher
- Elsevier BV
- Published
- 2013-09
- Volume
- 424
- Pages
- 99-103
- ISSN
- 0009-8981 (ISSN-L)
- OpenAlex
- W2019900254
- Cited by
- 327
- References
- 39
- FWCI
- 16.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.